Respiratory Tests

NAAT tests at the point of care have the potential to revolutionize the diagnosis of respiratory virus infections.

Excellence at the point of care

While some respiratory diseases are chronic, others are infectious. This means that the conditions are transmitted to people from other individuals or organisms.

Talis is built on a foundation of world-class science and engineering. We are dedicated to transforming and revolutionizing the way we diagnose highly infectious diseases. The next-generation products we are creating and commercializing for the point of care are simple to use.

Disease State

Since the emergence of the SARS-CoV-2 global pandemic in 2019, to date, we’ve seen the development of extremely effective rapid molecular diagnostic COVID-19 tests, and have access to highly effective vaccines.

Talis One
COVID-19 Test

Central lab-quality molecular testing of SARS-CoV-2 for a variety of care settings—less than 30 minutes from sample to results.

COVID-19 POC Antigen Test

A front-line choice for quick, high volume SARS-CoV-2 POC antigen testing. Talis is an authorized distributor of the GenBody COVID-19 Ag test.

Related Articles

June 15, 2022

Sexually Transmitted Infections and Disease: the Silent Pandemic

Twenty-five years ago, the Institute of Medicine (IOM) published a report on confronting sexually transmitted diseases (STDs) as the “hidden epidemic of tremendous health and economic consequence in the United…
May 13, 2022

COVID-19: It’s Not Over Yet

It’s hard to believe that it’s been more than 2 years since the World Health Organization (WHO) declared COVID-19 a global pandemic on March 11, 2020. At that time, the…
March 16, 2022

COVID-19 Testing for Travel—What Your Patients Need to Know

Whether upcoming travel is for relaxation, business, or a combination of both, testing for COVID-19 is likely an integral part of the trip, especially when traveling by air. There are…
February 22, 2022

Omicron and COVID-19 testing: What healthcare providers need to know

As the SARS-CoV-2 omicron variant (B.1.1.529) rapidly became the dominant strain in South Africa in late 2021, public health officials around the globe recognized that a new, highly transmissible form…

Join Our Newsletter

Subscribe to our newsletter for information about our products and company updates.


    The GenBody COVID-19 Ag Test and the Talis One COVID-19 Test System are for use under Emergency Use Authorization (EUA) only. For In Vitro Diagnostic (IVD) use. For prescription use only. Talis is an authorized distributor of the GenBody COVID-19 Ag test.

    © Talis and Talis One are trademarks of Talis Biomedical Corporation. All Rights Reserved.

    *Additional testing solutions are currently in development and not available for sale.